Insmed | INSM - Lucro Operacional





Lucro Operacional Alterar Data
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
DBV Technologies USD -34.28M 6.83M 2025-09
Gilead Sciences USD 2.68B 284M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Novartis USD 4.06B 521M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03